Marksans Pharma Ltd.

NSE: MARKSANS | BSE: 524404 | ISIN: INE750C01026 | Industry: Pharmaceuticals
| Mid-range Performer
166.6700 1.63 (0.99%)
NSE Oct 01, 2025 15:31 PM
Volume: 532.3K
 

logo
Marksans Pharma Ltd.
01 Jun 2015, 12:00AM
166.67
0.99%
Karvy
The company reported revenue growth of 8.9% for Q4FY15 over Q4FY14 and annual revenue reported a growth of 26.4% for FY15 over FY14.The company's Europe & UK segment reported growth of 25.7% while the US & North America reported growth of 65.3%. The improved product mix is reflected in operating margins which to 23.2% from 19.2% in FY14
Number of FII/FPI investors increased from 153 to 159 in Jun 2025 qtr.
More from Marksans Pharma Ltd.
Recommended